← Back
$ALNY All transactions

ALNYLAM PHARMACEUTICALS, INC.

▼ SELL 10b5-1 Plan

$ Value

$2.3M

Shares

5,358

Price

$436

Filed

Aug 15

Insider

Name

Ausiello Dennis A

Title

CIK

0001381994

Roles

Director

Transaction Details

Transaction Date

2025-08-14

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

13,305

Footnotes

All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025. | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $430.39 to $431.24. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $432.10 to $433.06. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $433.59 to $434.56. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $434.69 to $435.66. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $435.79 to $436.35 The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $436.84 to $437.83 The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $437.85 to $438.71 The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $438.91 to $439.89 The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $440.24 to $440.93 The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $441.41 to $442.11 The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $442.44 to $443.10 The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | The shares of ALNY common stock are held in a trust, of which the reporting person's spouse is the trustee. | The stock option was fully vested as of July 1, 2020. | The stock option was fully vested as of May 18, 2023. | The stock option was fully vested as of July 1, 2021. | The stock option was fully vested as of May 16, 2025. | The stock option was fully vested as of July 15, 2022. | The stock option was fully vested as of May 18, 2024.

Filing Info

Accession No.

0001735276-25-000079

Form Type

4

Issuer CIK

0001178670

Ausiello Dennis A's History

Date Ticker Type Value
2025-08-14 ALNY M $648K
2025-08-14 ALNY M $661K
2025-08-14 ALNY M $682K
2025-08-14 ALNY M $791K
2025-08-14 ALNY M $693K
2025-08-14 ALNY M $656K
2025-08-14 ALNY $855K
2025-08-14 ALNY $839K
2025-08-14 ALNY $912K
2025-08-14 ALNY $3.3M

Other Insiders at ALNY (90d)

Insider Bought Sold Last
Greenstreet Yvonne
Chief Executive Officer
$5.3M 2026-03-04
SUPRAN BRYAN
EVP, CLO and Secretary
2026-03-02
Poulton Jeffrey V.
EVP, Chief Financial Officer
$2.2M 2026-03-04
Garg Pushkal
EVP Chief R&D
$4.9M 2026-03-05
Tanguler Tolga
EVP, Chief Commercial Officer
$1.9M 2026-03-04
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
$2.8M 2026-03-05
McLaughlin Melissa
Chief Human Resources Officer
$1.3M 2026-04-06